Meisner Derek M

Chief Legal Officer & Corp SecAcumen Pharmaceuticals, Inc. (ABOS) · full profile →Form 4 · filed Jan 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$53K
Net Open-Market Flow
-$53K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)10K$1.99$20K134K
Jan 7, 2026Sell(S)2K$1.99$3K145K
Jan 6, 2026Sell(S)7K$1.97$14K150K
Jan 6, 2026Sell(S)4K$1.97$7K146K
Jan 5, 2026Sell(S)4K$1.96$8K157K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-001262) within minutes of acceptance. Every field above traces to the original document. Verify it directly: